Search results
Disparities in direct oral anticoagulant initiation have declined in recent years: Study
Medical Xpress· 6 days agoHistorical disparities in initiation of direct oral anticoagulants (DOACs) for atrial fibrillation...
Tranexamic Acid Injection Reduces Bleeding After Mohs
Medscape· 4 hours agoAdverse effects associated with using the antifibrinolytic were rare.
Ban on rodenticide that kills wildlife fails in CT legislature. Advocates can’t give up the fight.
Hartford Courant· 2 days agoA proposed ban on second-generation anticoagulant rodenticides used as a controversial rodent...
Record $41M Jury Verdict for Medical Malpractice Awarded to Former Lawyer | Law.com
Law.com· 17 hours agoIn 2016, Pierce, a criminal defense attorney, suffered a catastrophic stroke resulting from medical...
Bayer (BAYRY) Q1 Earnings Fall Y/Y on Lower Product Sales
Zacks via Yahoo Finance· 2 days agoBayer's (BAYRY) Q1 earnings and sales decline year over year due to a fall in volumes for...
Why Platelet Count Matters
Verywell Health via Yahoo News· 7 days agoLow Platelet Ranges A platelet count below 150,000 per microliter is considered low. A low platelet count is called thrombocytopenia. Several conditions...
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for...
Morningstar· 1 day agoTOKYO and CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”)
5 Supplements You Shouldn't Take for Menopause, According to Dietitians
Eating Well via Yahoo News· 2 days agoJohn’s wort has been connected to reducing hot flashes in menopause, there’s just not enough...
Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update
Fontana Herald News· 2 days agoTalphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings ...
Q1 2024 Talphera Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 19 hours agoVincent Angotti Thank you, Raffi, and good afternoon, and thank you for joining us on the call. Today, I'll provide a status update of our NEPHRO CRRT study evaluating the nafamostat’s use as ...